| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |